Monday, November 04, 2019
Raybow Pharmaceutical, a global provider of pharmaceutical chemical services, has acquired the US-based company. UU., PharmAgra Labs.
Raybow is a global provider of outsourced services for contract development and manufacturing, pharmaceutical process development and manufacturing services. The Taizhou, China- based company has more than 1,400 employees worldwide. PharmAgra is a customized chemical research and development company based in Brevard, North Carolina , whose current services include personalized synthesis, process development and analytical and optimization services.
The acquisition of PharmAgra expands Raybow's global footprint and places it closer to its growing customer base in the US. UU. The facilities at Brevard will become the headquarters and research and development center for operations in North America. They will receive support from the sales and marketing offices in Los Angeles, California , Princeton , New Jersey and Copenhagen, Denmark.
Raybow Executive Director Bin Wang commented, "We are excited to welcome the PharmAgra team with this union that favors both companies. Raybow's European and American customers will appreciate the option of receiving contractual services in the U.S. The PharmAgra team in the USA has a recognized trajectory established during the 20 years it has been offering customized synthesis services In addition to the existing capacity ranging from grams to multiple tons, we now have the flexibility to meet the requirements of each phase of the outsourcing activities of our clients in different continents ".
Raybow plans an expansion project at the PharmAgra headquarters, adding more capacity and more staff to the Brevard headquarters.
Peter Newsome , co-founder of PharmAgra Labs noted, " Our future with Raybow fits perfectly with our long-term goals of providing greater chemical capabilities for our customers in all sectors."